BAG1 and breast carcinoma: Taken together, the data by Cutress et al (2003) and Millar et al (2009) are consistent with the role of BAG-1 as a prognostic biomarker in the oncotype DX assay, and demonstrate that a high nuclear BAG-1 expression identifies a group of breast cancers with good prognosis and with enhanced sensitivity to hormonal therapy.